Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-265-8 | CAS number: 10102-05-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 November 2002 to 16 December 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD, EU), to GLP, on the dihydrate
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Reference substance 002
- Cas Number:
- 32916-07-7
- Details on test material:
- - Name of test material (as cited in study report): Palladium(II)nitrate dihydrate
- Substance type: orange-brown powder
- Physical state: solid
- Analytical purity: 40.1% (+/- 0.1%) palladium
- Impurities (identity and concentrations): calcium, copper, iron, magnesium, lead 10 μg/g; silver, gold, iridium, platinum, rhodium, ruthenium 20 μg/g; silicon 30 μg/g
- Composition of test material, percentage of components: - Isomers composition:
- Purity test date: 21 October 2002
- Lot/batch No.: 2403/02-02
- Expiration date of the lot/batch: 21 October 2003
- Stability under test conditions: no data
- Storage condition of test material: room temperature in the dark; stable
- Other: [Please note that the dihydrate has a different CAS RN (32916-07-7) to the anhydrous form (10102-05-3)]
Constituent 1
Method
- Target gene:
- Histidine for S. typhimurium strains; tryptophan for E.coli WP2 uvrA
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9, microsomal fraction derived from Aroclor 1254-induced rat liver. The S9 mix contained 5% (v/v) S9 fraction in the first two studies and 10% (v/v) in the two further studies.
- Test concentrations with justification for top dose:
- Experiment 1: 3, 10, 33, 100, 333, 1000, 3300 and 5000 μg/plate for TA100 and WP2 uvrA.
Experiment 2: 3, 10, 33, 100, 333 and 666 μg/plate for TA15335, TA1537 and TA98.
Experiment 3: 3, 10, 33, 100 and 250 μg/plate for TA15335, TA1537 and TA98. 3, 10, 33, 100, 333 and 666 μg/plate for TA100 and WP2 uvrA.
Experiment 4: 10, 33, 100, 333 and 666 μg/plate for TA1535 and TA98 with S9 only (since not enough cytotoxicity was seen in experiment 3) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: soluble after vortexing
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- 650 μg/plate for TA100 without S9
- Positive control substance:
- sodium azide
- Remarks:
- 5 μg/plate for TA1535 without S9
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- 10 μg/plate for WP2 uvrA without S9
- Positive control substance:
- 9-aminoacridine
- Remarks:
- 60 μg/plate for TA1537 without S9
- Positive control substance:
- other: daunomycin
- Remarks:
- 4 μg/plate for TA98 without S9
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- With 5% S9: 1 μg/plate for TA1535, TA98 and TA100; 2.5 μg/plate for TA1537; 5 μg/plate for WP2 uvrA. With 10% S9: 2.5 μg/plate for TA1535, TA1537, TA98 and TA100; 10 μg/plate for WP2 uvrA
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 hr
NUMBER OF REPLICATIONS: plates prepared in triplicate.
Each strain was tested in two independent studies; a further study was performed with TA1535 and TA98 (with S9 only), since insufficient cytotoxicity was observed in one study where the highest dose was 250 μg/plate.
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
OTHER: - Evaluation criteria:
- The test substance was considered to be mutagenic if the number of revertant colonies was at least twice that of the spontaneous revertants and reproducible in at least one independently repeated experiment. However any mean plate count of less than 20 revertants was considered to be not significant.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- yes: TA1537, TA100. no: TA1535, TA98
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium, other: TA 1535; TA 98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: slight precipitation was seen at 3330 and 5000 μg/plate
- Other confounding effects:
RANGE-FINDING/SCREENING STUDIES: yes
COMPARISON WITH HISTORICAL CONTROL DATA: yes and acceptable minimum and maximum numbers of spontaneous revertants and revertants induced by the positive controls given in the report
ADDITIONAL INFORMATION ON CYTOTOXICITY: - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
In the study with TA1535 and TA98 with S9, a footnote to the table says the vehicle control used was DMSO, but there is no explanation of why and its use is not mentioned in the text.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
In an OECD Test Guideline 471 study, to GLP, palladium dinitrate dihydrate failed to induce an increase in mutation frequency in four Salmonella typhimurium strains (TA1535, TA1537, TA98 and TA100) and Escherichia coli strain WP2 uvr A, either with or without S9, when tested at up to the limits of cytotoxicity. - Executive summary:
The mutagenic potential of palladium dinitrate dihydrate was assessed in a reverse mutagenicity assay, conducted according to OECD Test Guideline 471 and to GLP. The test substance was assessed in four Salmonella typhimurium strains (TA1535, TA1537, TA98 and TA100) and in Escherichia coli WP2 uvrA, in an attempt to detect both base-pair substitution and frameshift mutations.
In a study with strains TA100 and WP2 uvrA (which also served as a range-finding study), without or with 5% S9 fraction in the S9 mix, the test substance precipitated at dose levels of 3330 and 5000 μg/plate. Cytotoxicity was seen at concentrations of 1000 μg/plate and above with TA100, and at 333 or 1000 μg/plate without and with S9, respectively, with WP2 uvrA. When tested with TA1535, TA1537 and TA98, without or with 5% S9 fraction in the S9 mix, at concentrations of up to 666 μg/plate cytotoxicity was seen at levels of 333 μg/plate and above. In a study in which the S9 mix contained 10% S9, cytotoxicity was observed in all the test strains, both with and without metabolic activation, apart from TA1535 and TA98 in the presence of S9 only. Since the highest dose used for these latter strains was only 250 μg/plate, a further experiment was performed in which the top dose was 666 μg/plate; toxicity was observed for both strains.
Palladium dinitrate dihydrate did not cause an increase in mutation in these studies, either with or without S9. In contrast, the known mutagens used as positive controls showed the expected mutagenic activity
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.